US$ 21.60
dsip mengengabe Deepa Camenga | Specialists DSIG | NGO Support
Description
1 XPO-1 inhibitor therapy The upregulation of XPO1 inactivates tumor suppressor anti-neoplastic function, facilitating the transport of tumor suppressor proteins from the nucleus to the cytoplasm

Phase 3 (COSMIC-312) study of cabozantinib (C) in combination with ate zolizumab (A) versus sorafenib (S) in patients (pts) with advanced hep atocellular carcinoma (aHCC) who have not received previous systemic a nticancer therapy

Maine, CAA): CB Lionel Nixon Jr
Journal of the Endocrine Society, 6 (7), bvac077

Epithalon Peptide and Melatonin Levels This study(11) was carried out on aging monkeys to determine the actions of Epithalon on melatonin levels

Minor Pain and Bleeding with injections
